The increased risk of skin cancer is persistent after discontinuation of psoralen + ultraviolet A: A cohort study

Journal of Investigative Dermatology

Volumn 121, Issue 2, 2003, Pages 252-258

  Nijsten, Tamar E C ^a   Stern, Robert S ^a,b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Basal cell carcinoma; Epidemiology; Psoriasis; Squamous cell carcinoma

Indexed keywords

PSORALEN;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CANCER SUSCEPTIBILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSORIASIS; PUVA; SKIN CANCER; SQUAMOUS CELL CARCINOMA; ULTRAVIOLET A RADIATION;

EID: 0042905776     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2003.12350.x     Document Type: Article

References (39)

1. Bavinck JNM, Vermeer BJ, van der Woude FJ, et al: Relation between skin cancer and HLA antigens in renal transplant recipients. N Engl J Med 325:843-848, 1991
2. Bruynzeel I, Bergman W, Hartevelt HM, et al: "High single-dose" European PUVA regimen also causes an excess of non-melanoma skin cancer. Br J Dermatol 124:49-55, 1991
3. Caforio ALP, Fortina AB, Piaserico S, et al: Skin cancer in heart transplant recipients: Risk factor analysis and relevance of immunosuppressive therapy. Circulation 102 (Suppl. III):III-222-III-227, 2000
4. Chuang TY, Heinrich LA, Schultz MD, Reizner GT, Kumm RC, Cripps DJ: PUVA and skin cancer. A historical cohort study on 492 patients. J Am Acad Dermatol 26:173-177, 1992
5. Davis MM, Hanke W, Zollinger TW, Montebello JF, Hornback NB, Norins AL: Skin cancer in patients with chronic radiation dermatitis. J Am Acad Dermatol 20:608-616, 1988
6. Daynes RA, Harris CC, Conner RJ, Eichwald EJ: Skin cancer development in mice exposed chronically to immunosuppressive agents. J Natl Cancer Inst 62:1075-1081, 1979
7. Dunnick JK, Forbes PD, Eustis SL, Hardisty JF, Goodman DG: Tumors of the skin in the HRA/Skh mouse after treatment with 8-methoxypsoralen and UVA radiation. Fundam Appl Toxicol 16:92-102, 1991
8. Forman AB, Roenigk HH Jr, Caro WA, Magid ML: Long-term follow-up of skin cancer in the PUVA-48 cooperative study. Arch Dermatol 16:108-116, 1987
9. Gasparro FP, Liao B, Foley PJ, Wang XM, McNiff JM: Psoralen photochemotherapy, clinical efficacy, and photomutagenicity: The role of molecular epidemiology in minimizing risk. Environ Mol Mutagen 31:105-112, 1998
10. Glynn RJ, Buring JE: Wave of measuring rates of recurrent events. Br Med J 312:364-367, 1996
11. Granstein RD, Morison WL, Kripke ML: Carcinogenicity of combined ultraviolet B radiation and psoralen plus ultraviolet A irradiation treatment of mice. Photodermatol Photoimmunol Photomed 9:198-202, 1992
12. Grodstein F, Speizer FE, Hunter DJ: A prospective study of incident squamous cell carcinoma of the skin in the nurses' health study. J Natl Cancer Inst 87:1061-1066, 1995
13. Hannuksela-Svahn A, Pukkala E, Laara E, Poikolainen K, Karvonen J: Psoriasis, its treatment, and cancer in a cohort of Finnish patients. J Invest Dermatol 114:587-590, 2000
14. Harris RB, Griffith K, Moon TE: Trends in the incidence of nonmelanoma skin cancers in southeastern Arizona, 1985-1996. J Am Acad Dermatol 45:528-536, 2001
15. Henseler T, Christophers E, Honigsmann H, Wolff K: Skin tumors in the European PUVA Study. Eight-year follow-up of 1643 patients treated with PUVA for psoriasis. J Am Acad Dermatol 16:108-116, 1987
16. Jensen P, Hansen S, Moller B, et al: Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 40:177-186, 1999
17. Karagas MR, Greenberg ER, Spencer SK, Stukel TA, Mott LA: Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA: New Hampshire Skin Cancer Study Group. Int J Cancer 81:555-559, 1999
18. Karagas MR, McDonald JA, Greenberg ER, Stukel TA, Weiss JE, Baron JA, Stevens MM. Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group. J Natl Cancer Inst 88:1848-1853, 1996
19. Katz KA, Marcil I, Stern RS: Incidence and risk factors associated with a second SCC or BCC in PUVA-treated psoriasis patients. J Invest Dermatol 118:1038-1043, 2002
20. Kelly GE, Meikle W, Ross Sheil AG: Effects of immunosuppressive therapy on the induction of skin tumors by ultraviolet irradiation in hairless mice. Transplantation 44:429-434, 1987
21. Kreimer-Erlacher H, Seidl H, Back B, Kerl H, Wolf P: High mutation frequency at Ha-ras exons 1-4 in squamous cell carcinomas from PUVA-treated psoriasis patients. Photochem Photobiol 74:323-330, 2001
22. Lindelof B, Sigugeirsson E, Tegner E, et al: PUVA and cancer: A large scale epidemiological study. Lancet 338:91-93, 1991
23. Lindelof B, Sigurgeirson B, Tegner E, et al: PUVA and cancer risk: The Swedish follow-up study. Br J Dermatol 141:108-112, 1999
24. London NJ, Farmery SM, Will EJ, Davison AM, Lodge JPA: Risk of neoplasia in renal transplant patients. Lancet 346:403-406, 1995
25. Maier H, Schemper M, Ortel B, Binder M, Honingsmann H: Skin tumors in photochemotherapy for psoriasis. A single-center follow-up of 496 patients. Dermatology 193:185-191, 1996
26. Marcil I, Stern RS: Squamous-cell cancer of the skin in patients given PUVA and cyclosporin: Nested cohort crossover study. Lancet 358:1042-1045, 2001
27. Mohankumar MN, Venkatachalam P, Prabhu BK, Jeevanram RK. Comparison of UV-induced unscheduled DNA synthesis in lymphocytes exposed to low doses of ionising radiation in vivo and in vitro. Mutat Res 447:199-207, 2000
28. Nataraj AJ, Wolf P, Cerroni L, Ananthaswamy HN. p53 mutation in squamous cell carcinomas from psoriasis patients treated with psoralen + UVA (PUVA). J Invest Dermatol 109:238-243, 1997
29. Parrish JA, Fitzpatrick TB, Tanenbaum L, Pathak MA. Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light. N Engl J Med 29:1207-1211, 1974
30. Peritz AE, Gasparro FP: Psoriasis, PUVA, and skin cancer-molecular epidemiology: The curious question of T→A transversions. J Invest Dermatol Symp Proc 4:11-16, 1999
31. Seidl H, Kreimer-Erlacher H, Back B, Soyer HP, Hofler G, Kerl H, Wolf P: Ultraviolet exposure as main initiator of p53 mutations in basal cell carcinomas from psoralen and ultraviolet A-treated patients with psoriasis. J Invest Dermatol 117:365-370, 2001
32. Servilla KS, Burnham DK, Daynes RA: Ability of cyclosporine to promote the growth of transplanted ultraviolet radiation-induced tumors in mice. Transplantation 44:291-295, 1987
33. Shore RE, Moseson M, Xue X, Tse Y, Harley N, Pasternack BS. Skin cancer after X-ray treatment for scalp ringworm. Radiat Res 157:410-418, 2002
34. Stern RS, Lange R: Non-melanoma skin cancer occurring in patients treated with PUVA five to ten years after first treatment. J Invest Dermatol 91:120-124, 1988
35. Stern RS, Laird N: The carcinogenic risk of treatments for severe psoriasis. Cancer 73:2759-2764, 1994
36. Stern RS, Thibodeau LA, Kleinermann RA, Parrish JA, Fitzpatrick TB: Risk of cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis. N Engl J Med 300:809-813, 1979
37. Stern RS, Laird N, Melski J, Parrish JA, Fitzpatrick TB, Bleich HL: Cutaneous squamous-cell carcinoma in patients treated with PUVA. N Engl J Med 310:1156-1161, 1984
38. Stern KS, Liebman EJ, Vakeva L: Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of non-melanoma skin cancer. PUVA Follow-up Study. J Natl Cancer Inst 90:1278-1284, 1998
39. Van Dam RM, Huang Z, Rimm EB, et al: Risk factors for basal cell carcinoma of the skin in men: Results from the health professionals follow-up study. Am J Epidemiol 150:459-468, 1999